Novavax Inc (NVAX)

Cash & Equivalents

$191.46M

Quarterly · Period ending: · USD

NVAX logo

NVAX Cash & Equivalents

Latest reported$191.46M
NVAX Quarterly Cash & Equivalents ($3.90M → $191.46M)
High-resolution chart · PNG

NVAX cash & equivalents history

Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Novavax Inc Cash & Equivalents — Quarterly (USD)
Period endingCash & Equivalents (USD)
11,437,000
8,893,000
14,864,000
10,059,000
12,285,000
14,693,000
700,000
1,000,000
2,800,000
300,000
1,000,000
7,200,000
8,300,000
9,200,000
3,800,000
4,800,000
5,800,000
6,800,000
2,500,000
2,100,000
3,000,000
3,900,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.